Table 1.
Type of cancer | Prevalence | Gender | Age | |||
N (%) | Female (N, %) |
Male (N, %) |
Below 15 (N, %) |
15–60 (N, %) |
Over 60 (N, %) |
|
Cervix | 49 (26.8) | 49 (43.0) | 0 (0) | 0 (0) | 35 (25.5) | 13 (40.6) |
Kaposi sarcoma |
40 (21.8) | 16 (14.0) | 24 (34.8) | 3 (30) | 35 (25.5) | 1 (3.1) |
Skin cancer | 22 (12.0) | 10 (8.8) | 12 (17.4) | 1 (10) | 15 (10.9) | 6 (18.8) |
Hodgkin's lymphoma |
10(5.5) | 2(1.8) | 8(11.6) | 3(30) | 4(2.9) | 2(6.3) |
Secondary lymph node malignancies |
10 (5.5) | 6 (5.3) | 4 (5.8) | 1 (10) | 4(2.9) | 5(15.6) |
non-Hodgkin's lymphoma |
9 (4.9) | 3(2.6) | 6(8.7) | 0(0) | 9(6.6) | 0(0) |
Breast | 9 (4.9) | 9 (7.9) | 0 (0) | 0 (0) | 8 (5.8) | 1 (3.1) |
Penis | 6 (3.3) | 0 (0) | 6 (8.7) | 0 (0) | 5 (3.6) | 1 (3.1) |
Female genital cancers* |
6(3.3) | 6(5.3) | 0(0) | 0(0) | 6(4.4) | 0(0) |
Liver | 4(2.2) | 3(2.6) | 1(1.5) | 0(0) | 3(2.2) | 1(3.1) |
Bone | 4 (2.2) | 3 (2.6) | 1 (1.5) | 2 (20) | 2 (1.5) | 0 (0) |
Gastrointestinal cancers** |
4(2.2) | 4 (3.5) | 0 (0) | 0 (0) | 4 (2.9) | 0 (0) |
Others | 10 (5.5) | 3(2.6) | 7 (10.1) | 0 (0) | 7 (5.1) | 1 (3.1) |
Total | 183 (100) | 114(100) | 69 (100) | 10 (100) | 137 (100) | 32 (100) |